[Prevalence of Campylobacter jejuni complement fixing antibody in healthy people].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Kajioka.
Explore the source record for details and available documents.
Paired samples of maternal sera, umbilical cord sera and amniotic fluids were tested for antibodies to BK virus (BKV) and for interferon content. It was found that two out of 14 pregnant women were antibody negative, the latter were estimated to be susceptible to BKV primary infection. In contrast, there was no foetal case among those which were at risk of foetal infection with BKV as judged from the presence of BKV antibody in maternal sera and interferon in the placentas. It might be hypothesized that BKV may be transmitted to the foetus only in the case of BKV primary infection of antibody-negative pregnant women with undetectable amount of interferon (IFN) in the placenta.
Explore the source record for details and available documents.
A total of 480 serum samples from donors including 384 children up to 10 years of age were examined by the hemagglutination-inhibition (HI) test for the rates of prevalence and age of acquisition of HI antibodies against JC virus and BK virus. Among 136 serum samples from various age groups, there were five (4%) with no detectable antibodies against BK or JC virus, 75 (55%) with antibodies against both viruses, 41 (30.1%) with antibodies against only BK virus and 26 (19%) with antibodies against only JC virus. The prevalence of antibodies against JC and BK viruses was 70.5% and 80.8%, respectively, and the mean HI titers (4 x 2n,n greater than or equal to 1) were 4.90 and 4.30. About 50% of the children had acquired antibodies against BK virus by 3 years of age and against JC virus by 6 years of age. These results indicate that dual latent infections with both viruses are common, although independent infections with either virus are predominant in the human population.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.